SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001843872-21-000013
Filing Date
2021-09-27
Accepted
2021-09-27 19:54:44
Documents
1
Period of Report
2021-09-25

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 4743
  Complete submission text file 0001843872-21-000013.txt   6062
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address
Haas Kevin Richard (Reporting) CIK: 0001843872 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 211283211